Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)
Axogen, Inc. Common Stock · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · Now $38.72
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS